TAS-205

TAS-205 · Taiho Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for TAS-205, covering 2020-04-20 to 2026-08-17. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 3 Study of TAS-205 in Patients With Duchenne Muscular Dystrophy（REACH-DMD） [Phase 3]